Samuel A. Hamood - 01 Oct 2021 Form 3 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role: Director
Signature: /s/ Sydney Gaylin, Attorney-in-Fact
Issuer symbol: FNCH
Transactions as of: 01 Oct 2021
Transactions value $: $0
Form type: 3
Filing time: 05 Oct 2021, 19:49:37 UTC
Previous filing: 15 Sep 2021
Next filing: 26 May 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney